We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

84 hedge funds and large institutions have $67.4M invested in VanEck Biotech ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $777K | Put options by funds: $689K

0% more funds holding

Funds holding: 84 → 84 (0)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

2.38% less ownership

Funds ownership: 20.24% → 17.86% (-2.4%)

23% less capital invested

Capital invested by funds: $87.5M → $67.4M (-$20.1M)

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
20
Reduced
22
Closed
14
Calls
$777K
Puts
$689K
Net Calls
+$88K
Net Calls Change
-$1.37M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$2.15M
2
Rockefeller Capital Management
Rockefeller Capital Management
New York
+$1.37M
3
Wells Fargo
Wells Fargo
California
+$1.27M
4
TRCT
Tower Research Capital (TRC)
New York
+$922K
5
VF
Virtu Financial
New York
+$712K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.25M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3.65M
3
RJFSA
Raymond James Financial Services Advisors
Florida
-$1.21M
4
UBS Group
UBS Group
Switzerland
-$574K
5
CWM
Cornerstone Wealth Management
Missouri
-$511K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
26
Atlas Capital Advisors
Wyoming
$664K – – –
GJIC
27
Gamble Jones Investment Counsel
California
$664K – – –
PAG
28
Private Advisor Group
New Jersey
$657K -$84.3K -698 -11%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$642K – – –
SBH
30
Segall Bryant & Hamill
Illinois
$602K +$24.2K +200 +4%
IFWM
31
Institute for Wealth Management
Colorado
$572K +$625K +5,170 New
TC
32
Telemus Capital
Michigan
$549K – – –
FNBOSM
33
First National Bank of South Miami
Florida
$524K +$496K +4,103 New
PA
34
Pinnacle Associates
New York
$453K -$263K -2,175 -35%
IAMOG
35
Investors Asset Management of Georgia
Georgia
$410K – – –
SC
36
Scotia Capital
Ontario, Canada
$405K -$67.7K -560 -13%
WJA
37
Williams Jones & Associates
New York
$398K +$6.04K +50 +1%
IA
38
IFP Advisors
Florida
$343K -$32.1K -266 -8%
SB
39
Suntrust Banks
Georgia
$338K +$50.4K +417 +16%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$326K -$4.25M -35,152 -92%
AB
41
Atlas Brown
Kentucky
$319K +$12.2K +101 +4%
PA
42
PFG Advisors
Arizona
$290K +$4.71K +39 +2%
First Manhattan
43
First Manhattan
New York
$238K – – –
B
44
Bailard
California
$233K +$32.9K +272 +15%
MML Investors Services
45
MML Investors Services
Massachusetts
$210K -$77.1K -638 -25%
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$188K – – –
FANJ
47
Financial Architects (New Jersey)
New Jersey
$174K – – –
EDRH
48
Edmond de Rothschild Holding
Switzerland
$139K – – –
AG
49
Advisor Group
Arizona
$124K +$7.01K +58 +5%
Citigroup
50
Citigroup
New York
$106K – – –
1
2
3 4

BBH Hedge Fund Activity: Q4 2018 in Review

84 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2018, worth a combined $67.4M — down 23% from $87.5M a quarter earlier.

Fund positioning in BBH was balanced in Q4 2018: 14 funds opened new positions, 14 closed out, 20 added to existing stakes and 22 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $2.15M. The largest seller was Susquehanna International Group, cutting an estimated $4.25M.

  • 84 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $67.4M of VanEck Biotech ETF stock for Q4 2018, down 23% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q4 2018 and 14 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2018 was Citadel Advisors, an estimated $2.15M added.
  • The largest VanEck Biotech ETF seller in Q4 2018 was Susquehanna International Group, an estimated $4.25M sold.

Based on aggregated 13F filings for Q4 2018.